Trials / Completed
CompletedNCT02292797
Assessment of the Rosacea Prevalence in the General Population
Assessment of the Prevalence of Rosacea in the General Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,000 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Multi-centre interventional cross-sectional prevalence study Assessment of the Rosacea Prevalence in the General Population.
Detailed description
Primary objective: Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prevalence assessment | Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2014-11-17
- Last updated
- 2014-11-17
Source: ClinicalTrials.gov record NCT02292797. Inclusion in this directory is not an endorsement.